期刊文献+

力尔凡治疗恶性胸腔积液的临床研究 被引量:7

Clinical study of lifein in the treatment of malignant pleural effusion
暂未订购
导出
摘要 目的:观察力尔凡治疗恶性胸腔积液的疗效及副作用。方法:对60例恶性胸腔积液患者引流尽胸腔积液后,腔内注入力尔凡30mg,B超检查,观察效果。结果:控制胸腔积液CR18例,PR27例,有效率达75%,不良反应主要是胸痛和发热。结论:力尔凡能有效控制胸腔积液,提高患者的生活质量,是治疗恶性胸腔积液的有效药物之一。 Objective:To observe the efficacy of Lifein in the malignant pleural effusions. Methods: Sixty patients with malignant pleural effusions were given Lifein 30rag 1 -2 times every week after completely giving out pleurat effusions, to observe the efficacy with B -ultrasonic test. Results: Pleural effusions were controlled, CR 18, PR 27, the overall response rate was 66.7% , the main side effects were chest pain and fever. Conclusion: Lifein can effectively control the malignant pleural effusions. Improve the life quality of patients, it is one of the effective drugs to treat the malignant pleural effusions.
出处 《现代肿瘤医学》 CAS 2008年第1期48-49,共2页 Journal of Modern Oncology
关键词 力尔凡 恶性胸腔积液 Lifein malignant pleural effusions
  • 相关文献

参考文献5

二级参考文献11

  • 1张天泽 徐光炜.肿瘤学[M].天津:天津技术出版社,1998.1402.
  • 2李前文 张风莹 等.rh-TNF,NBrb-IL-2联合应用治疗恶性腹腔积液的疗效观察[J].癌症,1994,13(2):22-24.
  • 3[1]Watanabe Y,et al. OK-432,Clinical,PP.120,1984,Editors:Hoshino,T. ,et al,Printed in Japan
  • 4[2]Sawai,k.et al. The 14th International Congress of Chemotherapy. Kyoto, June, 1985. Atracts: P-29-53
  • 5[3]Uchida,A. ,et al: Int.J.Cancer,31,1,1983.OK-432,A Streptococcal Preparation as a potent Biological Response Modifier. Editors:Ishida,N.,et al.PP44,1983,Printed in Japan
  • 6仝运科 陈天法 梅延兰 等.顺铂另足叶乙甙联合腔内化疗治疗恶性体腔积液[J].中华肿瘤杂志,1995,17(3):198-198.
  • 7Noriaki Tanaka, Akira Gouchi, Toshinori Ohara. Intraumoral injection of astreprococcal preparation, OK-432, before surgery for gastric cancer. Cancer, 1994,1574(12):3097-3103.
  • 8何波,吴耀华.高聚金葡素联用顺铂治疗恶性胸腹水74例的疗效观察[J].中国肿瘤临床,1998,25(8):623-624. 被引量:18
  • 9高珊,王继营,崔黎,黄丽春,朱玉昆,宋立友.晚期肺癌放化疗前后免疫功能改变的近期临床观察[J].实用肿瘤学杂志,1999,13(2):144-145. 被引量:45
  • 10张弘纲,孙燕.力尔凡合并化、放疗治疗恶性肿瘤的多中心临床研究[J].中国肿瘤临床,2001,28(4):282-287. 被引量:69

共引文献88

同被引文献43

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部